CAPPATO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.434
AS - Asia 1.669
EU - Europa 583
SA - Sud America 456
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 93
OC - Oceania 2
Totale 5.346
Nazione #
US - Stati Uniti d'America 2.356
SG - Singapore 863
CN - Cina 376
BR - Brasile 369
VN - Vietnam 215
FI - Finlandia 134
IT - Italia 119
DE - Germania 65
IE - Irlanda 58
NG - Nigeria 57
HK - Hong Kong 49
FR - Francia 47
CA - Canada 39
IN - India 38
SE - Svezia 38
GB - Regno Unito 35
NL - Olanda 31
AR - Argentina 29
BD - Bangladesh 25
MX - Messico 22
EC - Ecuador 20
IQ - Iraq 17
ID - Indonesia 16
TR - Turchia 12
PL - Polonia 11
RU - Federazione Russa 11
VE - Venezuela 11
ZA - Sudafrica 11
PH - Filippine 10
CO - Colombia 9
IL - Israele 8
UA - Ucraina 8
JP - Giappone 7
EG - Egitto 6
PY - Paraguay 6
ES - Italia 5
PE - Perù 5
SA - Arabia Saudita 5
KE - Kenya 4
NP - Nepal 4
PK - Pakistan 4
TN - Tunisia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
JO - Giordania 3
MY - Malesia 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
MA - Marocco 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.241
Città #
Singapore 362
Ashburn 225
Shanghai 205
San Mateo 161
Wilmington 154
Helsinki 134
San Jose 127
Chandler 121
The Dalles 120
Dallas 106
Beijing 95
Ho Chi Minh City 89
Council Bluffs 81
Princeton 77
Lawrence 74
Dublin 58
New York 58
Benin City 57
Santa Clara 51
Hong Kong 49
Milan 48
Hanoi 39
Paris 38
Los Angeles 37
São Paulo 34
Amsterdam 31
Phoenix 22
Rome 22
Orem 21
Buffalo 16
London 16
Chicago 13
Haiphong 11
Seattle 11
Boardman 10
Chennai 10
Fairfield 10
Montreal 10
Salem 10
Woodbridge 10
Abbiategrasso 9
Atlanta 9
Biên Hòa 9
Norwalk 9
Warsaw 9
Charlotte 8
Houston 8
Mumbai 8
Rio de Janeiro 8
Brooklyn 7
Falkenstein 7
Hanover 7
Mexico City 7
Porto Alegre 7
Quito 7
Salvador 7
Boston 6
Curitiba 6
Figino 6
Guayaquil 6
Johannesburg 6
Monmouth Junction 6
Richmond 6
San Antonio 6
Thái Nguyên 6
Brasília 5
Cairo 5
Campinas 5
Da Nang 5
Des Moines 5
Hải Dương 5
Leawood 5
Manchester 5
Ninh Bình 5
Toronto 5
Turin 5
Astoria 4
Baghdad 4
Barquisimeto 4
Bauru 4
Bradenton 4
Buenos Aires 4
Clearwater 4
Contagem 4
Denver 4
Guarulhos 4
Homewood 4
Lafayette 4
Lewistown 4
Millersburg 4
Moscow 4
Nairobi 4
Orinda 4
Pasadena 4
Philadelphia 4
Recife 4
Redmond 4
San Francisco 4
Sumaré 4
Tashkent 4
Totale 3.154
Nome #
Data for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation 102
Complications of catheter ablation: incidence, diagnosis and clinical management 101
A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia 96
The subcutaneous implantable cardioverter-defibrillator: Current trends in clinical practice between guidelines and technology progress 90
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary 90
Adenosine and Preexcitation Variants: Reappraisal of Electrocardiographic Changes 87
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) 86
The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations 86
Discordant junctional beats and preexcitation: what is the mechanism? 85
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial 84
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban 84
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation 84
Catheter ablation of atrial tachycardia in a patient with extracardiac Fontan repair: The utility of transaortic approach and pulmonary artery recording 82
Clinical and electrocardiographic features of complete heart block after blunt cardiac injury: A systematic review of the literature 82
Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications 81
Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis 81
Challenging arrhythmias in a Wolff-Parkinson-White patient: Different physiology and adjacent troubles 81
A narrow QRS tachycardia and cannon A waves: What is the mechanism? 80
The Year in Cardiology 2016: arrhythmias and cardiac implantable electronic devices 80
Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort 79
European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks 79
An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator 79
Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48 78
Sudden unexpected cardiac death as the first symptom in young people: some useful clinical information from a systematic standardized anatomical study 78
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation 77
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: apost hocanalysis of the X-VeRT trial 77
Nearly fatal ventricular arrhythmia following pacemaker implantation in a young female with complete heart block 77
An unusual case of acute respiratory failure in a patient with pulmonary veins stenosis late after catheter ablation of atrial fibrillation: a case report and the review of the literature 76
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 76
Nodo- and fasciculoventricular pathways: Electrophysiological features and a proposed diagnostic algorithm for preexcitation variants 75
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients 75
Right Bundle Branch Block as a Potential Cause of Pacemaker Malfunction 75
One for All - All for One: Different Patterns of AV Block in a Patient With Bifascicular Block 74
Junctional Beats and Short HV Interval: What More Do You Need? 73
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) 72
An Unusual Case of Complete AV Block 72
Treatment of inappropriate sinus tachycardia with ivabradine 71
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) 70
Negative concordance pattern in bipolar and unipolar recordings: An additional mapping criterion to localize the site of origin of focal ventricular arrhythmias 70
Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study 70
Long-Term Results of Cryoballoon Ablation for Atrial Fibrillation: Confirmation of an Early Promise 69
Pulmonary Vein Stenosis Following Radiofrequency Ablation of Atrial Fibrillation: Has It Become a Clinically Negligible Complication? 69
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 69
An Unusual Pattern of Ventricular Pre-Excitation: Electrophysiological and Genetic Substrate 69
Concurrent electrocardiographic repolarization abnormalities: What is the underlying channelopathy? 69
Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs) 69
Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study 69
Supraventricular arrhythmia with discordant electrocardiographic features: What is the arrhythmia mechanism? 68
An unusual WPW syndrome: What is the preexcitation variant? 67
Premature ventricular extrastimulus without His or ventricular capture: An unexpected response during AV nodal reentrant tachycardia 67
Long-term follow-up after radiofrequency ablation of ectopic atrial tachycardia in young patients 67
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies 65
An unusual pattern of Para-Hisian pacing: The role of infra-Hisian conduction delay 64
Commotio Cordis and complete heart block: Where is the block level? 64
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II 64
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1- epidemiology, pathophysiology, and diagnosis 63
Repetitive wide-QRS arrhythmia after remote myocarditis: What is the mechanism? 62
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes 62
Junctional beats and pure His bundle pacing: Surface ECG appraisal in an atypical preexcitation variant 61
Para-Hisian pacing maneuver: A pitfall in the pitfall 61
An unexpected cause of wide QRS tachycardia in a young woman 61
Short and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation 60
Mechanical Block of a Manifested Accessory Pathway: What Is the Preexcitation Variant? 60
Para-Hisian Pacing: New Insights of an Old Pacing Maneuver 60
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 60
An Uncommon Block of a Common Circuit 60
Tailored treatment strategies: a new approach for modern management of atrial fibrillation 60
Para-CS pacing maneuver: further evidence of left atrionodal connections 60
Introduction 58
Notch Filtering of Intracardiac Recordings: Improving Quality or Masking Reality? 57
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials 56
Small reentry in a mega coronary sinus: Anatomical and high-density activation mapping 55
Is It Complete Left Bundle Branch Block? Just Ablate the Right Bundle 55
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2 - care pathways, treatment, and follow-up 51
Totale 5.346
Categoria #
all - tutte 38.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022373 0 0 0 66 2 1 11 61 28 64 108 32
2022/2023569 159 3 74 11 38 28 4 41 96 78 28 9
2023/2024525 19 80 80 12 19 48 63 51 9 8 49 87
2024/2025648 16 7 5 1 1 76 26 33 121 176 91 95
2025/20262.092 325 134 220 348 53 62 384 110 94 145 125 92
2026/2027838 370 105 321 42 0 0 0 0 0 0 0 0
Totale 5.346